Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
Takahashi T, Beppu T, Hidaka Y, Hosoya T. Takahashi T, et al. Among authors: hosoya t. Clin Exp Hypertens. 2021 Nov 17;43(8):730-741. doi: 10.1080/10641963.2021.1950752. Epub 2021 Aug 23. Clin Exp Hypertens. 2021. PMID: 34425059
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study.
Hosoya T, Sano T, Sasaki T, Fushimi M, Ohashi T. Hosoya T, et al. Clin Exp Nephrol. 2020 Mar;24(Suppl 1):44-52. doi: 10.1007/s10157-019-01802-w. Epub 2019 Nov 21. Clin Exp Nephrol. 2020. PMID: 31754882 Free PMC article. Clinical Trial.
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study.
Hosoya T, Sano T, Sasaki T, Fushimi M, Ohashi T. Hosoya T, et al. Clin Exp Nephrol. 2020 Mar;24(Suppl 1):53-61. doi: 10.1007/s10157-019-01818-2. Epub 2019 Dec 3. Clin Exp Nephrol. 2020. PMID: 31792640 Free PMC article. Clinical Trial.
Effects of febuxostat on serum urate level in Japanese hyperuricemia patients.
Yamamoto T, Hidaka Y, Inaba M, Ishimura E, Ooyama H, Kakuda H, Moriwaki Y, Higami K, Ohtawara A, Hosoya T, Nishikawa H, Taniguchi A, Ueda T, Yamauchi T, Fujimori S, Mineo I, Yamanaka H. Yamamoto T, et al. Among authors: hosoya t. Mod Rheumatol. 2015 Sep;25(5):779-83. doi: 10.3109/14397595.2015.1016257. Epub 2015 Jun 12. Mod Rheumatol. 2015. PMID: 25671406 Clinical Trial.
1,155 results